Endo’s COO resigns

CHADDS FORD, Pa. The COO of generic drug company Endo Pharmaceuticals has announced her resignation, the company announced Wednesday.

Endo said COO Nancy Wysenski will resign effective Sept. 1 to attend to family matters.

“I thank Nancy Wysenski for her contributions to the successful transition of Endo over the past two years,” CEO David Holveck said in a statement. “She has been instrumental in supporting our strong revenue growth, the diversification of the business and in strengthening our commercial capabilities.”